Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Mäntyjärvi R[au]:

Lipocalins as allergens. Mäntyjärvi R et al. Biochim Biophys Acta. (2000)

1,3-Diaminopropane rapidly inhibits protein synthesis and virus production in BKT-1 cells. Tuomi K et al. FEBS Lett. (1980)

BDA20, a major bovine dander allergen characterized at the sequence level, is Bos d 2. Rautiainen J et al. J Allergy Clin Immunol. (1997)

Search results

Items: 1 to 50 of 174

1.

Psoriasin, a calcium-binding protein with chemotactic properties is present in the third trimester amniotic fluid.

Porre S, Heinonen S, Mäntyjärvi R, Rytkönen-Nissinen M, Perola O, Rautiainen J, Virtanen T.

Mol Hum Reprod. 2005 Feb;11(2):87-92. Epub 2004 Dec 22.

PMID:
15615860
2.

Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy.

Saarelainen S, Taivainen A, Rytkönen-Nissinen M, Auriola S, Immonen A, Mäntyjärvi R, Rautiainen J, Kinnunen T, Virtanen T.

Clin Exp Allergy. 2004 Oct;34(10):1576-82.

PMID:
15479273
3.

Detection of mouse and rat urinary aeroallergens with an improved ELISA.

Korpi A, Mäntyjärvi R, Rautiainen J, Kaliste E, Kalliokoski P, Renström A, Pasanen AL.

J Allergy Clin Immunol. 2004 Apr;113(4):677-82. Erratum in: J Allergy Clin Immunol. 2004 Jun;113(6):1226.

PMID:
15100673
4.

Probing the mechanisms of low immunogenicity of a lipocalin allergen, Bos d 2, in a mouse model.

Immonen A, Saarelainen S, Rautiainen J, Rytkönen-Nissinen M, Kinnunen T, Mäntyjärvi R, Virtanen T.

Clin Exp Allergy. 2003 Jun;33(6):834-41.

PMID:
12801321
5.

The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells.

Kinnunen T, Buhot C, Närvänen A, Rytkönen-Nissinen M, Saarelainen S, Pouvelle-Moratille S, Rautiainen J, Taivainen A, Maillère B, Mäntyjärvi R, Virtanen T.

Eur J Immunol. 2003 Jun;33(6):1717-26.

6.

Threshold levels of purified natural Bos d 2 for inducing bronchial airway response in asthmatic patients.

Zeiler T, Taivainen A, Mäntyjärvi R, Tukiainen H, Rautiainen J, Rytkönen-Nissinen M, Virtanen T.

Clin Exp Allergy. 2002 Oct;32(10):1454-60.

PMID:
12372125
7.

Lipocalin allergen Bos d 2 is a weak immunogen.

Saarelainen S, Zeiler T, Rautiainen J, Närvänen A, Rytkönen-Nissinen M, Mäntyjärvi R, Vilja P, Virtanen T.

Int Immunol. 2002 Apr;14(4):401-9.

PMID:
11934876
8.

Two new variants of the lipocalin allergen Bos d 2.

Rautiainen J, Auriola S, Konttinen A, Virtanen T, Rytkönen-Nissinen M, Zeiler T, Mäntyjärvi R.

J Chromatogr B Biomed Sci Appl. 2001 Nov 5;763(1-2):91-8.

PMID:
11710588
9.

Search for the determinants of allergenicity in proteins of the lipocalin family.

Rouvinen J, Virtanen T, Mäntyjärvi R.

J Chromatogr B Biomed Sci Appl. 2001 May 25;756(1-2):199-206.

PMID:
11419713
10.

Lipocalins as allergens.

Mäntyjärvi R, Rautiainen J, Virtanen T.

Biochim Biophys Acta. 2000 Oct 18;1482(1-2):308-17. Review.

PMID:
11058771
11.

Important animal allergens are lipocalin proteins: why are they allergenic?

Virtanen T, Zeiler T, Mäntyjärvi R.

Int Arch Allergy Immunol. 1999 Dec;120(4):247-58. Review.

PMID:
10640908
12.

Allergy to lipocalins: a consequence of misguided T-cell recognition of self and nonself?

Virtanen T, Zeiler T, Rautiainen J, Mäntyjärvi R.

Immunol Today. 1999 Sep;20(9):398-400. Review. No abstract available.

PMID:
10462739
13.

Mutant derivatives of the main respiratory allergen of cow are less allergenic than the intact molecule.

Kauppinen J, Zeiler T, Rautiainen J, Rytkönen-Nissinen M, Taivainen A, Mäntyjärvi R, Virtanen T.

Clin Exp Allergy. 1999 Jul;29(7):989-96.

PMID:
10383601
14.
15.

T cell epitopes of a lipocalin allergen colocalize with the conserved regions of the molecule.

Zeiler T, Mäntyjärvi R, Rautiainen J, Rytkönen-Nissinen M, Vilja P, Taivainen A, Kauppinen J, Virtanen T.

J Immunol. 1999 Feb 1;162(3):1415-22.

16.

Probing the molecular basis of allergy. three-dimensional structure of the bovine lipocalin allergen Bos d 2.

Rouvinen J, Rautiainen J, Virtanen T, Zeiler T, Kauppinen J, Taivainen A, Mäntyjärvi R.

J Biol Chem. 1999 Jan 22;274(4):2337-43.

17.

A bovine dander allergen, comparative modeling, and similarities and differences in folding with related proteins.

Santa H, Saarela JT, Laatikainen R, Rautianen J, Virtanen T, Rytkönen M, Mäntyjärvi R.

J Protein Chem. 1998 Oct;17(7):657-62.

PMID:
9853680
18.

Molecular and crystal properties of Bos d 2, an allergenic protein of the lipocalin family.

Rautiainen J, Auriola S, Rouvinen J, Kauppinen J, Zeiler T, Novikov D, Virtanen T, Mäntyjärvi RA.

Biochem Biophys Res Commun. 1998 Jun 29;247(3):746-50.

PMID:
9647765
19.

Tissue localization of bovine dander allergen Bos d 2.

Rautiainen J, Rytkönen M, Syrjänen K, Pentikäinen J, Zeiler T, Virtanen T, Mäntyjärvi R.

J Allergy Clin Immunol. 1998 Mar;101(3):349-53.

PMID:
9525451
20.

Recombinant allergen fragments as candidate preparations for allergen immunotherapy.

Zeiler T, Taivainen A, Rytkönen M, Rautiainen J, Karjalainen H, Mäntyjärvi R, Tuomisto L, Virtanen T.

J Allergy Clin Immunol. 1997 Dec;100(6 Pt 1):721-7.

PMID:
9438477
21.

BDA20, a major bovine dander allergen characterized at the sequence level, is Bos d 2.

Rautiainen J, Rytkönen M, Virtanen T, Pentikäinen J, Zeiler T, Mäntyjärvi R.

J Allergy Clin Immunol. 1997 Aug;100(2):251-2. No abstract available.

PMID:
9275148
22.

Humoral responses to bovine dust in dairy farmers with allergic rhinitis.

Rautiainen M, Virtanen T, Ruoppi P, Nuutinen J, Mäntyjärvi R.

Acta Otolaryngol Suppl. 1997;529:169-72.

PMID:
9288301
23.

Molecular analysis of allergenic proteins in bovine dander.

Rautiainen J, Pentikäinen J, Rytkönen M, Linnala-Kankkunen A, Pelkonen J, Virtanen T, Mäntyjärvi R.

Allergy. 1996 Jun;51(6):378-82.

PMID:
8837659
24.

Complementary DNA cloning of the predominant allergen of bovine dander: a new member in the lipocalin family.

Mäntyjärvi R, Parkkinen S, Rytkönen M, Pentikäinen J, Pelkonen J, Rautiainen J, Zeiler T, Virtanen T.

J Allergy Clin Immunol. 1996 Jun;97(6):1297-303.

PMID:
8648026
25.

HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years.

Syrjänen K, Nurmi T, Mäntyjärvi R, Ilonen J, Syrjänen S, Surcel HM, Yliskoski M, Väyrynen M, Chang F, Saarikoski S.

Cytopathology. 1996 Apr;7(2):99-107.

PMID:
9074659
26.

Immune reactivity of cow-asthmatic dairy farmers to the major allergen of cow (BDA20) and to other cow-derived proteins. The use of purified BDA20 increases the performance of diagnostic tests in respiratory cow allergy.

Virtanen T, Zeiler T, Rautiainen J, Taivainen A, Pentikäinen J, Rytkönen M, Parkkinen S, Pelkonen J, Mäntyjärvi R.

Clin Exp Allergy. 1996 Feb;26(2):188-96.

PMID:
8835127
27.

cDNA cloning and protein analysis of a bovine dermal allergen with homology to psoriasin.

Rautiainen J, Rytkönen M, Parkkinen S, Pentikäinen J, Linnala-Kankkunen A, Virtanen T, Pelkonen J, Mäntyjärvi R.

J Invest Dermatol. 1995 Nov;105(5):660-3.

28.

Subpopulations of non-coding control region variants within a cell culture-passaged stock of BK virus: sequence comparisons and biological characteristics.

Johnsen JI, Seternes OM, Johansen T, Moens U, Mäntyjärvi R, Traavik T.

J Gen Virol. 1995 Jul;76 ( Pt 7):1571-81.

PMID:
9049364
29.

Homology of a bovine allergen and the oligomycin sensitivity-conferring protein of the mitochondrial adenosine triphosphate synthase complex.

Parkkinen S, Rytkönen M, Pentikäinen J, Virtanen T, Mäntyjärvi R.

J Allergy Clin Immunol. 1995 Jun;95(6):1255-60.

PMID:
7797794
30.
31.
32.

Quantification of a major bovine allergen by a two-site immunometric assay based on monoclonal antibodies.

Ylönen J, Virtanen T, Rytkönen M, Mäntyjärvi R.

Allergy. 1994 Oct;49(9):707-12.

PMID:
7535020
33.

Random amplified polymorphic DNA genotyping of Mycobacterium malmoense.

Kauppinen J, Mäntyjärvi R, Katila ML.

J Clin Microbiol. 1994 Jul;32(7):1827-9.

34.

Affinity purification of the major bovine allergen by a novel monoclonal antibody.

Ylönen J, Virtanen T, Horsmanheimo L, Parkkinen S, Pelkonen J, Mäntyjärvi R.

J Allergy Clin Immunol. 1994 May;93(5):851-8.

PMID:
8182227
35.

Risk factors associated with cervical human papillomavirus infections: a case-control study.

Kataja V, Syrjänen S, Yliskoski M, Hippelïnen M, Väyrynen M, Saarikoski S, Mäntyjärvi R, Jokela V, Salonen JT, Syrjänen K.

Am J Epidemiol. 1993 Nov 1;138(9):735-45.

PMID:
8237988
36.

Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.

Heinonen O, Syrjänen S, Soininen H, Talasniemi S, Kaski M, Mäntyjärvi R, Syrjänen K, Riekkinen P Sr.

Neurosci Lett. 1993 Jan 4;149(1):67-70.

PMID:
8469384
37.

Use of antibodies against a synthetic peptide of the E6 protein of human papillomavirus (HPV) type 16 for the diagnosis of genital HPV lesions.

Tosi P, Pallini V, Cintorino M, Bugnoli M, Covacci A, Petracca R, Syrjänen S, Del Vecchio MT, Mäntyjärvi R, Ruggiero P, et al.

Cytopathology. 1993;4(1):3-15.

PMID:
8384016
39.

Detection of airborne reindeer epithelial antigen by enzyme-linked immunosorbent assay inhibition.

Reijula K, Virtanen T, Halmepuro L, Anttonen H, Mäntyjärvi R, Hassi J.

Allergy. 1992 Jun;47(3):203-6.

PMID:
1510231
40.

Nasal sensitization of dairy farmers to bovine epithelial and urinary antigens.

Rautiainen M, Ruoppi P, Jägerroos H, Nuutinen J, Mäntyjärvi R, Virtanen T.

Rhinology. 1992 Jun;30(2):121-7.

PMID:
1411097
42.

Prognostic factors in cervical human papillomavirus infections.

Kataja V, Syrjänen S, Mäntyjärvi R, Yliskoski M, Saarikoski S, Syrjänen K.

Sex Transm Dis. 1992 May-Jun;19(3):154-60.

PMID:
1523531
43.

Clinical course of cervical human papillomavirus lesions in relation to coexistent cervical infections.

Yliskoski M, Tervahauta A, Saarikoski S, Mäntyjärvi R, Syrjänen K.

Sex Transm Dis. 1992 May-Jun;19(3):137-9.

PMID:
1326128
44.

JC virus infection and Alzheimer's disease: reappraisal of an in situ hybridization approach.

Heinonen O, Syrjänen S, Mäntyjärvi R, Syrjänen K, Riekkinen P.

Ann Neurol. 1992 Apr;31(4):439-41.

PMID:
1316732
45.

IgG and IgE antibody responses to cow dander and urine in farmers with cow-induced asthma.

Ylönen J, Mäntyjärvi R, Taivainen A, Virtanen T.

Clin Exp Allergy. 1992 Jan;22(1):83-90.

PMID:
1551038
46.

Long- and short-term variability of airborne bovine epithelial antigen concentrations in cowsheds.

Virtanen T, Eskelinen T, Husman K, Mäntyjärvi R.

Int Arch Allergy Immunol. 1992;98(3):252-5.

PMID:
1392627
47.

Effect of interferon gamma on the sensitivity of bovine-papilloma-virus(BPV1)-transformed cell lines to cell-mediated cytotoxicity.

Laatikainen A, Schultz-Suhonen L, Mäntyjärvi R.

Cancer Immunol Immunother. 1992;35(3):205-10.

PMID:
1322243
48.

Integration of bovine papillomavirus type 1 DNA and analysis of the amplified virus-cell junctions in transformed primary mouse fibroblasts.

Agrawal R, Pelkonen J, Rytkönen M, Mäntyjärvi RA.

J Gen Virol. 1992 Jan;73 ( Pt 1):201-6.

PMID:
1309860
49.

Comparison of the antigenic and allergenic properties of three types of bovine epithelial material.

Ylönen J, Mäntyjärvi R, Taivainen A, Virtanen T.

Int Arch Allergy Immunol. 1992;99(1):112-7.

PMID:
1282840
50.

Verrucous carcinoma of the penis successfully treated with interferon.

Pyrhönen S, Maiche AG, Mäntyjärvi R.

Br J Urol. 1991 Jul;68(1):102-4. No abstract available.

PMID:
1873677

Supplemental Content

Loading ...
Support Center